Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
about
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancersMast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic processDownregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cellsNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesIncreased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient miceIdentification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor FamilyVstm3 is a member of the CD28 family and an important modulator of T-cell functionCutting edge: TIGIT has T cell-intrinsic inhibitory functionsRecognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.Identification of CD112R as a novel checkpoint for human T cells.DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients.CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort.Expression of CD226 is associated to but not required for NK cell education.Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination.Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuliCritical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in miceDevelopment of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line.Balancing natural killer cell activation through paired receptors.TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection.Recognition of tumors by the innate immune system and natural killer cells.A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DCDNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma.Cell surface signaling molecules in the control of immune responses: a tide model.Immunosurveillance and therapy of multiple myeloma are CD226 dependent.The TIGIT/CD226 axis regulates human T cell functionIncreased Soluble CD155 in the Serum of Cancer Patients.Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host DiseaseApoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor.Nectin-2 (CD112) Is Expressed on Outgrowth Endothelial Cells and Regulates Cell Proliferation and Angiogenic Function.TIGIT predominantly regulates the immune response via regulatory T cells.Cytolytic responses: cadherins put out the fire.Immunosurveillance and immunotherapy of tumors by innate immune cells.Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumorsAccelerated tumor growth in mice deficient in DNAM-1 receptorCancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor
P2860
Q24294932-3280A0B6-19A1-442D-8E78-5F2E66369279Q24296718-69E0C785-601A-45FA-8E19-AA22F7202C14Q24616413-D81D5F16-E616-499B-8D81-D882EBC6A280Q24654966-02345277-06DA-4E21-A2FA-33E9CD6B317DQ26825652-061F275B-F214-4A5F-85B5-FF322E6992D8Q27330218-C8407747-A364-454D-A859-E203D5489BA7Q28115550-C51BACFF-83BC-4DF1-9E55-324F5855E7AFQ28512622-D2D759CA-BE9A-480F-BF28-07085433318CQ28594957-300E425E-0F6E-4F51-96F6-020A35218E04Q30402088-CDAC5E25-85D5-4596-B907-B8C7DD22765EQ30716850-5D3BB41B-B871-4FCD-9B21-413F4FEF6A42Q33289401-C367D809-74BE-48BB-A5A6-708841356CF7Q33436859-86FCE327-BAE9-4330-A5A7-10874597673EQ33458907-8B7302D6-564D-4385-87D9-BF87094EA1ECQ33661286-EE39DB21-39EC-429A-8E92-290304222543Q33766787-CBAF7071-71A7-4724-9CD1-0CFCA8C42418Q33778981-23A9A5EB-4CB4-447C-A0BD-2AEC25078020Q33927042-44F858B0-1758-4F72-84B1-4333146B654DQ34276582-CE14BCF2-3B2B-421A-B902-0361599D49C6Q34302464-1BACFB46-8480-4E7B-9BAD-FF11C7D95F2CQ34465877-0DB0080E-374C-4276-8762-575B8060C34AQ34471375-8F143C84-8AFC-4B3D-BA27-EB62235CE077Q34494794-C072D522-D924-4100-B5ED-A84F223A7E36Q34496462-5435B1CA-73B0-46E5-8ECC-627CEBAEAD04Q34938832-D1C36494-595E-4E6D-BA62-3B2E4D521862Q35209066-8EDC2619-DC68-4D0A-96F0-B8B0127E63A2Q35223235-A90B10E6-76BC-4786-8030-34A6A2BB19F7Q35719883-92AF8C69-B833-4B66-82D9-464E139EC444Q35884216-16D87A98-0223-4307-A7FF-1F7AE63BA115Q35980806-F5DDDBB3-22CA-4CBB-A93B-62045EF9A047Q36039542-3E287950-FF36-4CB3-9EE6-AE86E90E0912Q36131729-8BCB8DDB-EE1F-458B-85C8-AE9C1CCF079AQ36145995-74E3FBCD-E5CD-44A7-B642-A201E35779BEQ36266506-A6027666-43E8-492B-9805-4C336711E699Q36388525-501BAD89-B976-4437-AD1C-FC926AF4C2D7Q36471212-44850F3F-A6DC-4A2E-BC28-5C662850226CQ36652172-E304019A-9160-42E3-8BB6-3813EC7F29C9Q37019651-D5B4B1C1-8BBE-4435-A22D-8684029815FAQ37019655-C3ADD080-C4C7-4F90-8524-9F891974511FQ37252683-52772E3F-C28E-4B8A-A7ED-A805EF0CF2C4
P2860
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@ast
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en-gb
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@nl
type
label
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@ast
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en-gb
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@nl
prefLabel
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@ast
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en-gb
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@nl
P2093
P921
P3181
P356
P1476
Functional characterization of ...... 55) and nectin-2 (PRR-2/CD112)
@en
P2093
Akira Shibuya
Akitomo Miyamoto
Kazuko Shibuya
Lewis L Lanier
Satoko Tahara-Hanaoka
Satoshi Yamazaki
Shin-Ichiro Honda
Yuko Onoda
P3181
P356
10.1093/INTIMM/DXH059
P407
P577
2004-04-01T00:00:00Z